Irbesartan EP Impurity A

1-(Pentanoylamino)-N-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide;|1-(Pentanoylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide;|1-(pentanoylamino)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]cyclopentane-1-carboxamide|1-Pentanoylamino-cyclopentanecarboxylic Acid [2-(1H-Tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide;|1-Pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide ;|1-Pentanoylamino-cyclopentanecarboxylic Acid [2'-(1H-Tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide;|Irbesartan EP Impurity A ; Irbesartan USP Related Compound A ; Irbesartan Metabolite "SR-49498" ;|Irbesartan EP Impurity A;SR 49498; Irbesartan impurity A; Irbesartan Related Compound A;|Irbesartan Related Compound A;|Irbesartan USP Related Compound A ; Irbesartan Metabolite "SR-49498" ; 1-Pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide ;|N-((2-(1H-Tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide|N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide;|USP Irbesartan USP Related Compound;